
Sutykine Capsule (Sunitinib 50mg/25mg/12.5mg) is an oral targeted therapy used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Manufacturer | Intas Pharmaceuticals |
| Generic Name | Sunitinib |
| Strength | 50mg-25mg-12-5mg |
| Pack size | 70 Capsules |
| Used For | Renal Cell Carcinoma, Gastrointestinal Stromal Tumors, and Pancreatic Neuroendocrine Tumors |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
Stops signaling pathways that tumors use for growth and blood vessel formation.
Buy Sutykine Sunitinib 50mg/25mg/12.5mg Capsules from our trusted and licensed international pharmacy. We supply authentic generic anticancer medications in bulk to patients, hospitals, doctors, clinics, and healthcare professionals across many countries, including Colombia, Peru, the Philippines, Venezuela, Panama, Ecuador, Namibia, South Africa, Zimbabwe, Bahrain, Cyprus, Egypt, Iran, Iraq, Israel, Jordan, Palestine, Qatar, Saudi Arabia, the United Arab Emirates, China, Canada, Brazil, Mexico, Russia, Thailand, Malaysia, Singapore, Vietnam, South Korea, Taiwan, Indonesia, the United States, and more.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.